Physician

Cardiology

Dr. Richard J. Candela, MD

Richard Candela practices Cardiology. He went to medical school at The Ohio State University College of Medicine. Doctor Richard J. Candela, MD is a published physician as well. He has 31 publications published. The latest was: Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for acute myocardial infarction: develo...

Publications

Clinical characteristics and long-term outcome of patients in whom congestive heart failure develops after thrombolytic therapy for Acute myocardial infarction: develo...
Bilateral renal Artery occlusion: an unusual presentation of atrial fibrillation and hypertrophic cardiomyopathy.
Clinical importance of thrombocytopenia occurring in the hospital phase after administration of thrombolytic therapy for Acute myocardial infarction. The Thrombolysis ...
Successful prolonged local infusion of urokinase for the hypothenar hammer Syndrome.
Minimizing the risk of inappropriately administering thrombolytic therapy (Thrombolysis and Angioplasty in Myocardial Infarction [TAMI] study group).
Outcome of patients with diabetes mellitus and Acute myocardial infarction treated with thrombolytic agents. The Thrombolysis and Angioplasty in Myocardial Infarction ...
IntraCoronary stenting compared with conventional therapy for abrupt vessel closure complicating Coronary angioplasty: a matched case-control study.
Thrombolytic therapy in patients requiring cardiopulmonary resuscitation.
Rapid thrombus dissolution by continuous infusion of urokinase through an intraCoronary perfusion wire prior to and following PTCA: results in native coronaries and pa...
Identification of Acute myocardial infarction patients suitable for early hospital discharge after aggressive interventional therapy. Results from the Thrombolysis and...
The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in Acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (...
Myocardial infarction with minimal Coronary atherosclerosis in the era of thrombolytic reperfusion. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) St...
Usefulness of a pericardial friction rub after thrombolytic therapy during Acute myocardial infarction in predicting amount of myocardial damage. The TAMI Study Group.
Fate of patients with Acute myocardial infarction with patency of the infarct-related vessel achieved with successful thrombolysis versus rescue angioplasty.
Consequences of reocclusion after successful reperfusion therapy in Acute myocardial infarction. TAMI Study Group.
Stroke and Acute myocardial infarction in the thrombolytic era: clinical correlates and long-term prognosis.
Brachial approach to emergency cardiac catheterization during thrombolytic therapy for Acute myocardial infarction. TAMI Study Group.
One-year outcome after therapy with tissue plasminogen activator: report from the Thrombolysis and Angioplasty in Myocardial Infarction trial.
Complex Coronary angioplasty: use of a new microprobe balloon catheter.
Combined tissue-type plasminogen activator and prostacyclin therapy for Acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Stu...
Favorable early and long-term prognosis following Coronary bypass surgery therapy for myocardial infarction: results of a multicenter trial. TAMI Study Group.
A randomized controlled trial of intravenous tissue plasminogen activator and early intravenous heparin in Acute myocardial infarction.
Thrombolysis and Angioplasty in Myocardial Infarction (TAMI-1) trial: influence of infarct location on arterial patency, left ventricular function and mortality.
Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of Acute myocardial infarction.
Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis.
Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with Acute myocardial infarction.
Characteristics and outcome of patients in whom reperfusion with intravenous tissue-type plasminogen activator fails: results of the Thrombolysis and Angioplasty in My...
Emergency coronary artery bypass surgery preserves global and regional left ventricular function after intravenous tissue plasminogen activator therapy for Acute myoca...
Comparison of two dose regimens of intravenous tissue plasminogen activator for Acute myocardial infarction.
A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in Acute myocardial infarction.

Schools

Ohio State University College of Medicine
Riverside Methodist Hospital

Procedures Preformed

Cardiac Catheterization (incl. Coronary Angiography)

Conditions Treated

Angina and Acute Coronary Syndrome
Coronary Artery Disease (CAD)
Hyperlipidemia
Hypertension

Doctors Specialties

Cardiology

Accepted Insurances

Education

Riverside Methodist Hospitals - OhioHealth
The Ohio State University College of Medicine

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Mahmoud Houmsse, MD This Doctor is OpenDoctor Recommended.
	Dr. Ayesha K. Hasan, MD This Doctor is OpenDoctor Recommended.
	Dr. David R. Richards, DO This Doctor is OpenDoctor Recommended.
	Dr. Zhenguo Liu, MD This Doctor is OpenDoctor Recommended.
	Dr. John Stanko Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Peter M. Bittenbender, MD This Doctor is OpenDoctor Recommended.
	Dr. Charles J. Hardebeck, MD This Doctor is OpenDoctor Recommended.
	Dr. Jaret D. Tyler, MD This Doctor is OpenDoctor Recommended.